5.59 mmol/lPost-menopausal women with breast cancer had significantly higher total antioxidant capacity (5.59 ± 2.38 mmol/l) compared to controls (4.43 ± 2.66 mmol/l), with P = 0.023.
Nigeriacancer du seinpublished 2021Nigerian journal of clinical practicePubMeddocument of 6 observations
26.3 %Breast lump was the second most common clinical indication, reported in 26.3% of women.
Nigeriacancer du seinobserved 2020–2021published 2024West African journal of medicinePubMeddocument of 12 observations
78.5 %78.5% of the participants stated that they practiced breast self-examination.
Nigeriacancer du seinpublished 2023BMC women's healthPubMeddocument of 12 observations
Breast cancer is the most prevalent cancer type globally.
Nigeriacancer du seinpublished 2024Nigerian journal of clinical practicePubMeddocument of 5 observations
Plasma D-dimer and fibrinogen levels were significantly higher in breast cancer patients than in healthy controls.
Nigeriacancer du seinpublished 2021Cancer investigationPubMeddocument of 4 observations
0.41 aORParticipants with highly educated fathers were 60% less likely to have high-grade breast cancer (adjusted odds ratio 0.41; 95% confidence interval 0.20 to 0.84) compared to those with less-educated fathers.
Nigeriacancer du seinpublished 2021Annals of global healthPubMeddocument of 7 observations
18.8 %Among patients with resectable breast cancer in Nigeria between January 2010 and December 2018, 18.8% (57/303) experienced recurrence.
Nigeriacancer du seinobserved 2010–2018published 2021International journal of cancerPubMeddocument of 12 observations
379 casesThe study recruited 379 histologically confirmed breast cancer cases and 403 controls.
Nigeriacancer du seinobserved October 2016 to May 2017published 2022The Pan African medical journalPubMeddocument of 5 observations
78 %Between 78% and 88% of patients across Ghana, Kenya, and Nigeria completed tests for hormone receptors and HER2.
Ghana · Kenya · Nigeriacancer du seinobserved 2014 to 2017published 2021BMJ openPubMeddocument of 13 observations
51 patientsFifty-one (85%) patients reported no positive family history of breast cancer.
Nigeriacancer du seinpublished 2025Journal of oncology pharmacy practice : official publication of the International Society PubMeddocument of 14 observations
22 patientsPatients diagnosed with breast cancer one year before the study were 22 (39.3%) of the participants.
Nigeriacancer du seinpublished 2025Journal of oncology pharmacy practice : official publication of the International Society PubMeddocument of 14 observations
80 %Pain was the most common symptom among breast cancer patients undergoing chemotherapy in Delta State, Nigeria, reported by 80% of participants.
Nigeriacancer du sein · painpublished 2026The Pan African medical journalPubMeddocument of 5 observations
1.6 odds_ratioPracticing breast self-examination was associated with a higher probability (odds ratio 1.6) of detecting lesions <2 cm.
Nigeriacancer du seinpublished 2021PloS onePubMeddocument of 6 observations
0.575 h_squaredThe APOBEC C>T somatic mutation signature had a significant heritable component (h² = 0.575, p = 0.010).
Nigeriacancer du seinpublished 2019International journal of cancereurope_pmcdocument of 4 observations
7.2 %Of those who did not receive surgery, disease progression occurred in 7.2% (n = 9/125).
Nigeriacancer du seinpublished 2026Psycho-oncologyPubMeddocument of 11 observations
73.8 %The majority of breast cancer patients presented with stage 3 disease, accounting for 73.8%.
Nigeriacancer du seinpublished 2023West African journal of medicinePubMeddocument of 8 observations
25.5 per_100000Nigeria has the highest age-standardized breast cancer mortality rate in Africa, at 25.5 per 100,000.
Nigeriacancer du seinpublished 2025BMC health services researchPubMed
26.09 %Middle-aged individuals had 26.09% knowledge about alcohol as a breast cancer risk factor.
Nigeriacancer du seinpublished 2024JCO global oncologyPubMeddocument of 12 observations
36.1 %The prevalence of psychological distress was 36.1% among 72 patients with breast cancer post-surgery in Northern Nigeria.
Nigeriacancer du seinpublished 2025BMC psychiatryPubMeddocument of 3 observations
9 %9.0% of the respondents had good general knowledge of breast cancer.
Nigeriacancer du seinpublished 2024West African journal of medicinePubMeddocument of 7 observations
80 %In Nigeria, 80% of breast cancer is diagnosed at an advanced stage.
Nigeriacancer du seinpublished 2025JAMA network openPubMeddocument of 8 observations
281.5 daysThe median total treatment time was 281.5 days among young adult females with breast cancer in Nigeria.
Nigeriacancer du seinpublished 2025BMC cancerPubMeddocument of 11 observations
77.1 %Most participants (77.1%) reported poor treatment adherence.
Nigeriacancer du seinpublished 2026BMC cancerPubMeddocument of 8 observations
0.33 beta_coefficientIn the TCGA dataset, seven common SNPs within or near GNB5 were significantly associated with an increased proportion of APOBEC signature contribution (beta = 0.33, 95% CI = 0.21–0.45) at genome-wide significance.
Nigeriacancer du seinpublished 2019International journal of cancereurope_pmcdocument of 4 observations
33.83 %Among 3,263 breast histopathology records reviewed from 2015 to 2023, 33.83% of breast cancer cases were in middle-aged women (40–59 years).
Nigeriacancer du seinobserved 2015 to 2023published 2025Scientific reportsPubMeddocument of 12 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.